Theta Burst Transcranial Focused Ultrasound as a Novel Treatment for Cervical Dystonia
NCT: NCT07690514 · RECRUITING
Brief Summary
This study is a single-blinded, randomized control study that aims to recruit 48 participants. Participants will be "randomized" into one of the study arms of the study: active stimulation to GPi, active stimulation to DN, or sham stimulation. The purpose of the study is to look into the effects of LIFUS in patients with cervical dystonia. The participation will include seven study visits, at least 24 hours apart. All study visits will take place at TWH. The first visit is a screening visit. Visits 2-6 will be on consecutive days. Visit 7 will be a week from Visit 6 or from your last day of LIFUS, whichever comes first.
Frequently Asked Questions
What is Theta Burst Transcranial Focused Ultrasound as a Novel Treatment for Cervical Dystonia?
Theta Burst Transcranial Focused Ultrasound as a Novel Treatment for Cervical Dystonia is a clinical trial registered under NCT07690514. Current status: RECRUITING.
What is the status of NCT07690514?
The current status of NCT07690514 (Theta Burst Transcranial Focused Ultrasound as a Novel Treatment for Cervical Dystonia) is: RECRUITING.
When did Theta Burst Transcranial Focused Ultrasound as a Novel Treatment for Cervical Dystonia start?
Theta Burst Transcranial Focused Ultrasound as a Novel Treatment for Cervical Dystonia started on 2024-11-18.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.